Backgrounds/Aims: The appropriate surgical treatment was investigated for T1b gallbladder (GB) cancer through a retrospective analysis of the clinical outcomes of patients with incidental T1 GB cancer. Methods: Patients with T1 GB cancer who were incidentally diagnosed while undergoing a simple cholecystectomy at Chungnam University Hospital from January 2004 to December 2017 were enrolled. Overall, 39 patients with T1 GB cancer, 17 patients with T1a, and 22 patients with T1b were included. We retrospectively analyzed the patients' clinical and pathologic findings and follow-up results. Results: Among the 6490 patients who underwent cholecystectomy during the study period, 165 patients were diagnosed with GB cancer (T1=42 [25.5%]). The risk factor associated with recurrence and cancer-related death in patients with T1 GB cancer was lymphovascular invasion (recurrence, p=0.028; death, p= 0.004). In the T1b group, the 5-year disease-free survival (DFS) rate showed a statistical difference between patients with and without lymphovascular invasion (45.7% vs. 83.6%, p=0.048). There was no statistically significant difference in 5-year DFS and overall survival rate between simple cholecystectomy and extended cholecystectomy in T1b GB cancer with lymphovasular invasion (p=0.054 and p=0.091, respectively). Conclusions: In incidental T1b GB cancer, extended cholecystectomy was not superior to simple cholecystectomy in terms of the 5-year DFS rate and nor in overall survival rate or recurrence rate, even when lymphovascular invasion was identified after simple cholecystectomy. Therefore, simple cholecystectomy may be recommended as a primary surgical strategy for T1b GB cancer. (Ann Hepatobiliary Pancreat Surg 2019;23:327-333)
INTRODUCTION
Gallbladder carcinoma is one of the most common malignant tumors of the biliary tract. However, it remains debated whether curative resection is the most beneficial treatment for improving long-term survival in patients with this malignancy. GB cancer that is limited to the mucosa (T1a) or the mucularis (T1b) is classified as early cancer. [1] [2] [3] Many studies recommend simple cholecystectomy as the surgical procedure of choice for T1a GB cancer, as it is a local disease. However, in the case of T1b GB cancer, several guidelines, including the National Comprehensive Cancer Network (NCCN) guidelines, recommend extended cholecystectomy as the initial treatment. [4] [5] [6] It may be premature to conclude that extended cholecystectomy should be the surgical treatment of choice for T1b GB cancer because there remain controversies such as tumor spreading. Some studies considered T1b GB cancer as a local disease and therefore suggested simple cholecystectomy as the treatment method. [7] [8] [9] [10] Recent studies have reported increased incidences of incidental diagnoses of T1 GB cancer, reaching up to 50-58%. [11] [12] [13] [14] Therefore, it is necessary to consider whether the surgical strategy will benefit the future recurrence rate and survival rate of simple cholecystectomy and extended cholecystectomy for these patients. In this retrospective study, we analyzed the clinicopathologic features of GB cancer to determine the predictive risk factors that affect recurrence and survival. This study aimed to establish the surgical criteria for patients with early GB cancer. 
MATERIALS AND METHODS

RESULTS
Characteristics of the study population
Types of surgical intervention
The surgical outcomes according to the surgical method are summarized in 
Lymphovascular invasion
Initially, we considered that lymph node metastasis would be the primary prognostic factor; however, among our patient population (n=39), none showed lymph node metastasis on the final pathology findings. Therefore, we proceeded to investigate lymphovascular invasion, which was pathologically observed in 2 cases (11.8%) in the T1a group and 8 cases (36.4%) in the T1b group (Table 3) . Tumor recurrence and gallbladder cancer-related deaths seemed to be associated with lymphovascular invasion based on the univariate analysis (p=0.028 and p=0.004, respectively).
Tumor location
In our investigation, we wanted to consider various prognostic factors. We, therefore, stratified the patients according to the tumor location (peritoneal or hepatic side). The AJCC 8th edition uses tumor location as a distinguishing factor between T2a and T2b disease. 15 In the T1a group, 13 cases (76.5%) were in the peritoneal side, and 4 cases (23.5%) were in the hepatic side. In the T1b group, 10 cases (45.5%) were in the peritoneal side, and 12 cases (54.5%) were in the hepatic side. Our univariate analysis showed that tumor location was not a significant prognostic factor of recurrence and DFS in T1 GB cancer (p=0.552 and p=0.192, respectively).
Recurrence
Recurrence was noted during the follow-up period in 6 patients with T1 GB cancer, including 1 case (6.3%)
with T1a tumor and 5 cases (22.7%) with T1b tumor ( 
Survival rate
In T1b cases, the 1-, 3-, and 5-year DFS rates were 92.3%, 84.6%, and 72.5%, respectively, in the simple cholecystectomy group, and 100%, 57.1%, and 57.1%, respectively, in the extended cholecystectomy group (p= 0.332); however, the differences were not statistically significant ( Fig. 2A ). In the T1b group, the 5-year DFS rate was statistically significantly different between patients with and without lymphovascular invasion (83.6% in patients without invasion, 45.7% in patients with invasion;
p=0.048) (Fig. 2B) . According to the surgical method, the showing no statistically significant differences (p=0.091) ( Fig. 3) . 
DISCUSSION
Incidental gallbladder cancer is defined as GB cancer that is histologically diagnosed after cholecystectomy for gallstone, cholecystitis, or gallbladder polyps, and its rate of detection ranges from 0.2% to 2.9%. 12, 17, 18 In the present study, incidental gallbladder cancer was diagnosed in 2.46% of our patients. When early GB cancer is con- In general, the rate of diagnosis of advanced-stage GB cancer is high. 2, 3 In our study, 123 of the 165 patients (75%) with an incidental diagnosis of GB cancer were confirmed to have stage T2 disease or higher at the time of diagnosis. Therefore, the level of research or evidence on the treatment of early GB cancer is, in fact, insufficient. Because the incidence of early gallbladder carcinoma has increased with the increasing use of laparoscopic cholecystectomy, 13, 14, 19 there is a growing need for surgical guidelines for early GB cancer. In Korea, a large-scale multicenter retrospective study was previously conducted to suggest the appropriate surgical method for T1 GB cancer. 20 That nationwide study concluded that simple cholecystectomy is an appropriate treatment for T1a GB cancer, and there was no evidence of the superiority of extended cholecystectomy for T1b GB cancer over simple cholecystectomy. Therefore, the above study serves as a basis for recommending simple cholecystectomy for T1b GB cancer. 8, 20 For T1a GB cancer, which is limited to the mucosa, simple cholecystectomy including the resection margin has been considered the optimal treatment. This is a part of the NCCN guideline and has also been recommended at the highest level in the Korean domestic guidelines. [4] [5] [6] 21 However, for T1b GB cancer, extended cholecystectomy is primarily recommended in the NCCN guideline, whereas other studies have shown that extended cholecystectomy was not more advantageous than simple cholecystectomy. [4] [5] [6] 8 Furthermore, we did not find a relationship between extended cholecystectomy of T1b GB cancer and improvement in survival rate, and we did not obtain evidence that lymph node dissection has a therapeutic effect. 20, [22] [23] [24] [25] [26] In other words, extended cholecystectomy was not superior to simple cholecystectomy in terms of survival rate and recurrence rate, and lymph node resection also did not improve the survival rate in T1b GB cancer.
Based on these findings, simple cholecystectomy is being recommended as the appropriate surgical therapy for T1b GB cancer. Other guidelines also recommend simple cholecystectomy for the treatment of T1b GB cancer. 8, 20, 21, 27, 28 Presence of lymph node metastasis is a well known prognostic factor in cancer and lymph node dissection is thought to be of benefit in raising survival rates. Although there is no definite guideline for the number of nodes to remove and the extent of resection in lymph node dissection in cholecystectomy, the 6th edition of the AJCC Staging Manual states, that removal of ＞3 lymph nodes is required to accurately determine the N stage. 15, 16 The increased in patients treated with extended cholecystectomy, but not statistically significant (p=0.054), and there was no statistically significant difference in overall survival (p=0.091) ( Fig. 3) .
Given that extended cholecystectomy does not show a superiority in survival or recurrent rates, although NCCN guidelines recommend extended cholecystectomy in T1b cancer patients but there are realistic difficulties in domestic application Moreover, the results of our institution are also consistent with the domestic trend, and the simple cholecystectomy in T1b GB cancer can be considered as an appropriate surgical approach. 4, 21 This study has some limitations. The number of patients with incidental gallbladder cancer was relatively small. Moreover, the retrospective design of this study is also a limitation (a randomized controlled trial would have been ideal). Further investigations through largescale randomized controlled trials are needed in the future.
In conclusion, extended cholecystectomy in T1 GB cancer does not offer an advantage in terms of the survival and recurrence rates. In T1b GB cancer, it seems questionable whether the recommendation for initially extended cholecystectomy including lymph node dissection is still valid. Therefore, when T1b GB cancer is inci-dentally diagnosed after a simple cholecystectomy, we believe that simple cholecystectomy may be recommended as the primary surgical strategy.
